Global Steroids Market Size By Type (Powder, Granule), By Application (Health care products, Daily diet), By Region, And Segment Forecasts, 2023 to 2032

The Global Steroids Market was valued at USD 13.2 billion in 2023 and is projected to reach USD 22.6 billion by 2031, expanding at a CAGR of 6.9% during the forecast period of 2023–2031. The market is primarily driven by the increasing demand for corticosteroids and anabolic steroids in the treatment of inflammatory diseases, hormonal disorders, and chronic illnesses, as well as their expanding application in sports medicine and veterinary healthcare. With growing awareness of hormone replacement therapies and the rising prevalence of conditions such as asthma, arthritis, and adrenal insufficiency, the market is witnessing sustained growth across pharmaceutical and clinical settings.

Drivers

1. Rising Incidence of Chronic and Autoimmune Diseases

The global burden of autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease has significantly increased. Corticosteroids are key treatment modalities in managing inflammation and immune response in such conditions, boosting market growth.

2. Expanding Use in Bodybuilding and Sports

Despite regulatory scrutiny, anabolic steroids continue to be used for muscle growth and performance enhancement. Increased fitness awareness and the growth of competitive sports have kept demand high, especially in regions with less stringent enforcement.

3. Veterinary Applications and Livestock Industry Growth

Steroids are used to treat inflammation, allergies, and hormone deficiencies in animals, particularly livestock and companion animals. This has led to rising demand from veterinary clinics and agricultural sectors.

Restraints

1. Stringent Regulatory Environment and Risk of Abuse

Due to potential side effects and misuse of anabolic steroids, several countries have placed strict regulations on their sale and prescription. These restrictions could impede market penetration and consumer access.

2. Side Effects and Health Risks

Long-term or unsupervised use of steroids can lead to adverse effects such as hormonal imbalance, liver damage, cardiovascular issues, and psychological disorders, limiting their acceptability in over-the-counter segments.

Opportunity

1. Development of Safer and Targeted Steroid Therapies

Innovations in drug delivery methods (e.g., topical, inhaled, and slow-release formulations) and the synthesis of selective steroid receptor modulators are opening new avenues for safer therapeutic applications, especially in chronic disease management.

2. Growth Potential in Emerging Economies

Emerging healthcare markets in Asia-Pacific, Latin America, and the Middle East & Africa are seeing a surge in pharmaceutical demand, improved healthcare infrastructure, and greater access to prescription medications—creating fertile ground for steroid market expansion.

Market by System Type Insights

By product type, corticosteroids dominated the market in 2023, accounting for over 60% of the total revenue. Their broad applications in managing inflammation, asthma, allergies, and autoimmune conditions contribute to their leadership. However, the anabolic steroid segment is anticipated to register faster growth during the forecast period, fueled by rising usage in sports medicine and hormone therapy.

Market by End-use Insights

In terms of end use, the hospitals & clinics segment emerged as the largest revenue contributor in 2023. Steroids are extensively used in inpatient care for a wide range of conditions. Meanwhile, the retail pharmacy segment is gaining traction, supported by rising prescription volumes and improved access to treatment for hormonal imbalances and inflammation-related disorders.

Market by Regional Insights

North America led the global steroids market in 2023, driven by high healthcare expenditure, extensive use in chronic disease management, and the presence of key pharmaceutical players. The Asia-Pacific region is expected to witness the highest growth rate through 2031, due to increasing disease burden, growing healthcare access, and rising investments in medical infrastructure.

Competitive Scenario

Key players in the global steroids market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Merck & Co., Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Cipla Inc., Organon & Co., and Hikma Pharmaceuticals PLC. These companies are actively investing in research and development to launch safer and more effective steroid-based therapies. Strategic mergers, expansions, and product approvals are central to their market positioning.

Scope of Work – Global Steroids Market

Report Metric Details

Market Size (2023) USD 13.2 billion

Projected Market Size (2031) USD 22.6 billion

CAGR (2023–2031) 6.9%

Market Segments Product Type (Corticosteroids, Anabolic Steroids), End-Use, Region

Growth Drivers Chronic disease prevalence, therapeutic and veterinary demand

Opportunities Safer therapies, emerging market expansion

Key Market Developments

April 2024: Pfizer announced a new inhaled corticosteroid therapy for pediatric asthma, enhancing localized treatment with reduced side effects.

January 2024: Cipla received approval for a biosimilar corticosteroid injection for inflammatory diseases in India and South Africa.

August 2023: